Safety End Points
Marion Lassalle
EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], and French National Health Insurance [CNAM]), Saint-Denis, France., France
Thien Le Tri
EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], and French National Health Insurance [CNAM]), Saint-Denis, France, France
Pauline Afchain
APHP, Hôpital Saint Antoine, Medical Oncology Department, Paris, France, France
Marine Camus-Duboc
Sorbonne Université, Centre de Recherche Saint Antoine, UMRS-938, Paris, France, France
Julien Kirchgesner, MD, PhD
Sorbonne Universit
Paris, France
Mahmoud Zureik
EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), France
Rosemary Dray-Spira
EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], and French National Health Insurance [CNAM]), Saint-Denis, France, France